{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:49Z","timestamp":1786119409195,"version":"build-2736575974"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/hjh.0b013e328334262f","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T10:33:20Z","timestamp":1261046000000},"page":"13-14","source":"Crossref","is-referenced-by-count":0,"title":["Spironolactone for all hypertensive patients?"],"prefix":"10.1097","volume":"28","author":[{"given":"Clive","family":"Rosendorff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210208","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jama.1967.03130240070013","article-title":"Effects of treatment on morbidity in hypertension.","volume":"202","year":"1967","journal-title":"JAMA"},{"key":"R2-4-20210208","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bedroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial \u2013 Blood Pressure Lowering Arm (ASCOT \u2013 BPLA): a multicenter randomized controlled trial","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"key":"R3-4-20210208","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2009","journal-title":"N Engl J Med"},{"key":"R4-4-20210208","first-page":"713","article-title":"Antihypertensive effect of spironolactone (SC-9420), steroidal antagonist [abstract]","volume":"20","author":"Hollander","year":"1959","journal-title":"Circulation"},{"issue":"10A","key":"R5-4-20210208","doi-asserted-by":"crossref","first-page":"4F","DOI":"10.1016\/j.amjcard.2006.03.004","article-title":"Cardiovascular effects of aldosterone and postacute myocardial infarction pathophysiology","volume":"97","author":"Cohn","year":"2006","journal-title":"Am J Cardiol"},{"key":"R6-4-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-4-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-4-20210208","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"R9-4-20210208","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11906-007-0054-y","article-title":"Spironolactone use in resistant hypertension","volume":"9","author":"Carl","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"R10-4-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens"},{"key":"R11-4-20210208","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/HJH.0b013e328332b79b","article-title":"Does the ratio of serum aldosterone to plasma renin activity predict the efficiency of diuretics in hypertension Results of RENALDO.","volume":"28","author":"Parthasaraty","year":"2010","journal-title":"J Hypertens"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004872-201001000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:31Z","timestamp":1786039891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004872-201001000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328334262f","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}